SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-116629
Filing Date
2016-08-04
Accepted
2016-08-04 16:31:52
Documents
66
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v444754_10q.htm 10-Q 511396
2 EXHIBIT 10.1 v444754_ex10-1.htm EX-10.1 681203
3 EXHIBIT 31.1 v444754_ex31-1.htm EX-31.1 10229
4 EXHIBIT 31.2 v444754_ex31-2.htm EX-31.2 9958
5 EXHIBIT 32.1 v444754_ex32-1.htm EX-32.1 6838
  Complete submission text file 0001144204-16-116629.txt   4963716

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anip-20160630.xml EX-101.INS 953149
7 XBRL TAXONOMY EXTENSION SCHEMA anip-20160630.xsd EX-101.SCH 40637
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20160630_cal.xml EX-101.CAL 44892
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20160630_def.xml EX-101.DEF 273155
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20160630_lab.xml EX-101.LAB 306519
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20160630_pre.xml EX-101.PRE 305966
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 161807948
SIC: 2834 Pharmaceutical Preparations